Overview
Updated 14 Jul 2026
Christopher Ritchlin, MD, is Professor of Medicine (Part-Time), Chief, Division of Allergy, Immunology and Rheumatology at University of Rochester Medical Center. The public record shows 505 publications with 22,155 citations (h-index 67), centered on Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 17 companies, 3 NIH-funded awards (2001–2026).
- Most recent indexed publication: 2026 · Advances in therapy
- Top research focus: Spondyloarthritis Studies and Treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 53 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 205.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
Sponsor: University of Rochester
InvestigatorPhase 1RecruitingNCT05197530 - Teriparatide as a Chondroregenerative Therapy in OA
Sponsor: Christopher Ritchlin
InvestigatorPhase 2CompletedNCT03072147
Industry payments
Updated 14 Jul 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year202543 payments$17,601openpaymentsdata.cms.gov ↗
- UCB SAProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year202539 payments
NIH funding
Updated 14 Jul 2026
3 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
- ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2026$1,913,867UC2AR081029 - ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2025$600,000UC2AR081029 - ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2024$600,000UC2AR081029
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.
Arthritis & rheumatology (Hoboken, N.J.)
2026 - Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.
Rheumatology (Oxford, England)
2026 - Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.
Arthritis & rheumatology (Hoboken, N.J.)
2026
Most-cited worksby citation count (OpenAlex)
- 01Psoriatic Arthritis1,373 citations2017
- 02
- 03
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
400 Red Creek Drive, Suite 200, Rochester, NY 14623
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗ - Board Certified
Rheumatology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
- Member
Scientific Advisory Committee, National Psoriasis Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Secondary affiliationsappointments beyond the home institution
- Director
Clinical Immunology Research Unit, University of Rochester Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗ - Co-founder/Co-Director
URMC Psoriasis Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podtail.com ↗ - Principal site investigator
International Psoriatic Arthritis Research Team (IPART) database (one of six sites)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- Psound Bytes podcast (National Psoriasis Foundation)
Ep. 30: "Insights on the Prevention of Psoriatic Arthritis"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podtail.com ↗ - Video interview
Rheumatology Live: "Safety and Efficacy of Bimekizumab for Psoriatic Arthritis"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheum-live.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/christopher-ritchlin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/christopher-ritchlin-3a8869295
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Christopher-Ritchlin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
podtail.com/podcast/psound-bytes/ep-30-insights-on-the-prevention-of-psoriatic-arth
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podtail.com ↗ - Other
healio.com/news/rheumatology/20160601/video-ritchlin-discusses-new-markers-used-for-treatment-of-psoriasis-psoriatic-arthritis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - Other
medscape.com/viewarticle/959148
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Barr, MD
University of Rochester Medical Center
- 837
- publications
- 55
- h-index
- 32
- trials
Jonathan Steinberg, MD
University of Rochester Medical Center
- 379
- publications
- 69
- h-index
- 6
- trials
Jennifer Anolik, MD
University of Rochester Medical Center
- 197
- publications
- 53
- h-index
- 1
- trial